Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Infusion in Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00002922Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Feb 1997
- Primary completion
- Sep 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Eastern Cooperative Oncology Group. Primary endpoints: Objective Response Rate and Toxic effects. Started Feb 1997; status: completed.
02
Drugs
paclitaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00002922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002922.